Pablo Riera Freire, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 3 | 2020 | 70 | 0.960 |
Why?
|
| Receptors, Steroid | 1 | 2018 | 155 | 0.590 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2018 | 202 | 0.590 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 286 | 0.570 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 3386 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4462 | 0.250 |
Why?
|
| Gene Dosage | 1 | 2008 | 1252 | 0.240 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10481 | 0.230 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2020 | 1341 | 0.210 |
Why?
|
| Dihydroergotamine | 2 | 2020 | 20 | 0.210 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 9648 | 0.180 |
Why?
|
| Glioblastoma | 2 | 2013 | 3481 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2020 | 23403 | 0.130 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 642 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 987 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2020 | 3523 | 0.110 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 7722 | 0.110 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 9438 | 0.110 |
Why?
|
| Atlases as Topic | 1 | 2010 | 236 | 0.090 |
Why?
|
| Entropy | 1 | 2008 | 209 | 0.080 |
Why?
|
| DNA Damage | 1 | 2018 | 2432 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 8428 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2016 | 2967 | 0.070 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 496 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 2219 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2018 | 3086 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2017 | 3023 | 0.070 |
Why?
|
| Penaeidae | 1 | 2005 | 22 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14557 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2183 | 0.070 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 1941 | 0.060 |
Why?
|
| Heart | 1 | 2017 | 4467 | 0.060 |
Why?
|
| Genome | 1 | 2010 | 1808 | 0.050 |
Why?
|
| Computational Biology | 2 | 2013 | 3521 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2016 | 13033 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 3557 | 0.050 |
Why?
|
| Mice | 5 | 2020 | 81183 | 0.050 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2020 | 131 | 0.040 |
Why?
|
| Phylogeny | 1 | 2005 | 2803 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10638 | 0.040 |
Why?
|
| Host Cell Factor C1 | 1 | 2017 | 31 | 0.040 |
Why?
|
| Transcription Initiation Site | 1 | 2017 | 196 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 1940 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2017 | 3920 | 0.040 |
Why?
|
| Animals | 6 | 2020 | 168757 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 414 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 3647 | 0.030 |
Why?
|
| Bradycardia | 1 | 2017 | 307 | 0.030 |
Why?
|
| Genome, Human | 1 | 2008 | 4420 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2016 | 223 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 1106 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 893 | 0.030 |
Why?
|
| Oncogenes | 1 | 2020 | 1265 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1878 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2716 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2017 | 711 | 0.030 |
Why?
|
| Mitochondria | 1 | 2005 | 3520 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 8863 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 1701 | 0.020 |
Why?
|
| Neoplasms | 2 | 2010 | 21683 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2005 | 6544 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 2699 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 6314 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 3462 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2016 | 1294 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 713 | 0.020 |
Why?
|
| Histones | 1 | 2017 | 2599 | 0.020 |
Why?
|
| Semantics | 1 | 2010 | 584 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3617 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 5867 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 1783 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 1912 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 9386 | 0.020 |
Why?
|
| Echocardiography | 1 | 2017 | 5102 | 0.020 |
Why?
|
| Electron Transport Complex I | 1 | 2005 | 140 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1708 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16689 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2005 | 1005 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2005 | 954 | 0.010 |
Why?
|
| Apoptosis | 1 | 2018 | 9727 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 2256 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2020 | 12208 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 2634 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12788 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2013 | 5102 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2005 | 2309 | 0.010 |
Why?
|
| Genomics | 1 | 2013 | 5720 | 0.010 |
Why?
|
| Humans | 4 | 2020 | 744343 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2010 | 7729 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 21746 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 29063 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 13881 | 0.000 |
Why?
|
| Female | 1 | 2018 | 380194 | 0.000 |
Why?
|